Skip to main content

Tweets

Watch my video summary of abstracts #0380 and #0381 presented at the #ACR21 on #SickLeave and #WorkDisability in #axSpA by @ElenaNikiUK and colleagues. @RheumNow https://t.co/HWEyPoPJi0

Mrinalini Dey @DrMiniDey ( View Tweet )

4 years 8 months ago
SELECT-EARLY results for #upadacitinib in #RA 👉🏼UPA better than MTX for clinical response and remission 👉🏼⬆️rates of HZ, neutropenia, CPK elevations 👉🏼No new safety risks identified Abs#1692 #ACR21 @RheumNow https://t.co/wJy7MK4pyF https://t.co/YNpE1Axiw0
Mrinalini Dey @DrMiniDey ( View Tweet )
4 years 8 months ago
For Dr @LianneGensler managing axSpA requires a sundae🍨approach! How cool is that?!😎 This means that we need to take a holistic approach on the management of axSpA - both non/pharmacologic & there's no one magic pill to treat the disease. @RheumNow #ACR21 #RheumTwitter https://t.co/o0OjcEn16b
4 years 8 months ago
Sick Leave and Work Disability in Patients with AxSpA: Dr. Mrinalini Dey ( @DrMiniDey) discusses abstracts #0380 and #0381 presented at the #ACR21 annual meeting. https://t.co/Wm4qpxerYJ https://t.co/6CwPrZjqJT
Dr. John Cush @RheumNow ( View Tweet )
4 years 8 months ago
The Influence of Obesity on Choice of Biologic Agent in Rheumatoid Arthritis Dr. Richard Conway ( @RichardPAConway) reviews an abstract presented at #ACR21. https://t.co/PkJmpODz8v https://t.co/zuJjofka3B
Dr. John Cush @RheumNow ( View Tweet )
4 years 8 months ago
RheumNow’s expanded coverage of #ACR21 meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.

Dr. John Cush @RheumNow ( View Tweet )

4 years 8 months ago
great Thieves market another dx to consider for ? inflammatory arthritis swelling/stiffness post cold exposure Microgeodic Disease-digital swelling/pain likely from bone infarction 2/2 to cold induced vasospasm characteristic x ray/MRI findings on poster #ACR21 #meded https://t.co/eq0aOlcB7I
Adam J Brown @AdamJBrownMD ( View Tweet )
4 years 8 months ago
#ACR21 #IgG4 Q&A [Drs Stone/Perugino] 📌܄Igg4 in the blood/tissue is NOT diagnostic bec it can also be seen in others (malignancy..etc) 📌its more the presentation/ organ involvement see acr/eular guide: https://t.co/xBvu4r0TM3 https://t.co/WkiF6KyxGq
LiSa ◡̈︎ @rheumarhyme ( View Tweet )
4 years 8 months ago
Upadacitinib 56-wk efficacy/safety (mod to severe PsA) 🔹Comparable or ⬆️efficacy vs adalimumab 🔹Efficacy maintained, and 15mg vs 30mg doses similar at 56wks 🔹No new safety findings @ 56wks 🔹🚫inc risk VTE, MACE, cancer vs ada https://t.co/NlKvBrwDxB #ACR21 Abst#1345 @RheumNow

Pedro Castillo @_Castillo_Pedro ( View Tweet )

4 years 8 months ago
Echos in PsA, RA: 🔹Diastolic dysfxn: 52% of PsA and RA (!), controls 5% 🔹Mitral regurge PsA 84%, Ra 53%, controls 10% 🔹Mild pulmonary valve regurge higher in PsA (Diastolic dysfxn has been seen in prior RA studies) https://t.co/QCKR5itfYj #ACR21 Abst1308 @RheumNow

Pedro Castillo @_Castillo_Pedro ( View Tweet )

4 years 8 months ago
Supporting date for Ixekizumab in PsA with symptoms of axial involvement. 🔹Improvement in QoL (SF-36), ASDAS, BASDAI50 🔹Maintained at 52 weeks 🔹Stricter criteria (younger, ⬆️CRP) showed similar results https://t.co/QSJLQTxLcW #ACR21 Abst#3147 @RheumNow

Pedro Castillo @_Castillo_Pedro ( View Tweet )

4 years 8 months ago
Calcium hyperproficiency is a rare complication of vitamin D deficiency, where excess calcium from bone resorption forms complex structures resembling primary teeth. Neoformed teeth grow on different bones, such as this patient's hand, causing fractures and joint dysfunction. https://t.co/oGYCYkh1WD
Eduardo Valdés-Hevia 🦟 @Valdevia_Art ( View Tweet )
4 years 8 months ago
×